By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot

AddAnalogsCompare
Found partially in the 51 (31) ⓘFound partially in the 51 drug (31 of these, according to Kiberis statistics) in 0 selected book (author) ... hide
  Effect Influence Cases ⓘ  Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • t24.7 corrosion of third degree of hip and lower limb, except ankle and foot
  • 73%+18%5   Hidden. Need a subscription
    Ankle joints - E 73% (I 18%, 5 cases.); Тазобедренные суставы - E 48% (I -19%, 5 cases.)
  • 67%+24%14 read Causticum hahnemanni
    Ankle joints - E 67% (I 24%, 14 cases.); Тазобедренные суставы - E 46% (I 7%, 30 cases.)
  • 64%+2%7 read Ledum palustre
  • 60%+0%7 read Colchicum autumnale
    Ankle joints - E 60% (I 0%, 7 cases.); Тазобедренные суставы - E 42% (I -17%, 8 cases.)
  • 54%+15%8 read Calcarea fluorata
  • 53%+6%12 read Natrum muriaticum
    Ankle joints - E 53% (I 6%, 12 cases.); Тазобедренные суставы - E 46% (I 5%, 28 cases.)
  • 52%+7%8 read Calcarea phosphorica
    Ankle joints - E 52% (I 7%, 8 cases.); Тазобедренные суставы - E 75% (I 8%, 11 cases.)
  • 49%+12%4 read Staphysagria
    Ankle joints - E 49% (I 12%, 4 cases.); Тазобедренные суставы - E 35% (I -8%, 5 cases.)
  • 49%+5%13 read Silica terra
    Ankle joints - E 49% (I 5%, 13 cases.); Тазобедренные суставы - E 39% (I -3%, 12 cases.)
  • 49%+17%8 read Natrum sulphuricum
    Ankle joints - E 49% (I 17%, 8 cases.); Тазобедренные суставы - E 40% (I -6%, 17 cases.)
  • 48%-5%7 read Apis mellifica
    Ankle joints - E 48% (I -5%, 7 cases.); Тазобедренные суставы - E 48% (I -14%, 4 cases.)
  • 45%+8%10 read Calcarea carbonica
    Ankle joints - E 45% (I 8%, 10 cases.); Тазобедренные суставы - E 50% (I 15%, 26 cases.)
  • 43%+4%11 read Bryonia alba
    Ankle joints - E 43% (I 4%, 11 cases.); Тазобедренные суставы - E 35% (I -1%, 16 cases.)
  • 40%+7%14 read Sulphur
    Ankle joints - E 40% (I 7%, 14 cases.); Тазобедренные суставы - E 41% (I 11%, 34 cases.)
  • 40%+3%23 read Rhus toxicodendron
    Ankle joints - E 40% (I 3%, 23 cases.); Тазобедренные суставы - E 42% (I 2%, 51 cases.)
  • 40%-3%9 read Thuja occidentalis
    Ankle joints - E 40% (I -3%, 9 cases.); Тазобедренные суставы - E 10% (I -15%, 10 cases.)
  • 39%-17%10 read Echinacea compositum sn
    Ankle joints - E 39% (I -17%, 10 cases.); Тазобедренные суставы - E 73% (I 0%, 6 cases.)
  • 38%-11%7 read Arnica montana
    Ankle joints - E 38% (I -11%, 7 cases.); Тазобедренные суставы - E 37% (I -5%, 19 cases.)
  • 37%+12%17 read Phosphorus
    Ankle joints - E 37% (I 12%, 17 cases.); Тазобедренные суставы - E 31% (I 4%, 30 cases.)
  • 37%-4%9 read Kalium carbonicum
    Ankle joints - E 37% (I -4%, 9 cases.); Тазобедренные суставы - E 49% (I 2%, 34 cases.)
  • 37%+6%21 read Lycopodium clavatum
    Ankle joints - E 37% (I 6%, 21 cases.); Тазобедренные суставы - E 41% (I 2%, 30 cases.)
  • 36%-13%5 read Natrum carbonicum
  • 35%+10%14 read Pulsatilla nigricans
    Ankle joints - E 35% (I 10%, 14 cases.); Тазобедренные суставы - E 35% (I 3%, 36 cases.)
  • 35%+2%14 read Arsenicum album
    Ankle joints - E 35% (I 2%, 14 cases.); Тазобедренные суставы - E 45% (I 4%, 17 cases.)
  • 30%+4%3 read Tuberculinum
  • 30%+0%11 read Sepia officinalis
    Ankle joints - E 30% (I 0%, 11 cases.); Тазобедренные суставы - E 37% (I 4%, 19 cases.)
  • 29%-7%6 read Chelidonium majus
    Ankle joints - E 29% (I -7%, 6 cases.); Тазобедренные суставы - E 49% (I -2%, 7 cases.)
  • 25%-5%22 read Lachesis muta
    Ankle joints - E 25% (I -5%, 22 cases.); Тазобедренные суставы - E 45% (I 8%, 32 cases.)
  • 9%-39%5 read Traumeel s
  • 9%-33%6 read Chininum arsenicosum
    Ankle joints - E 9% (I -33%, 6 cases.); Тазобедренные суставы - E 29% (I -19%, 8 cases.)
  • 0%-3%7 read Carbo vegetabilis
    Ankle joints - E 0% (I -3%, 7 cases.); Тазобедренные суставы - E 31% (I 6%, 6 cases.)
  • Argentum nitricum read
  • Aurum metallicum read
  • Berberis vulgaris read
  • Cardiomil read
  • China officinalis read
  • Colocynthis read
  • Conium maculatum read
  • Crotalus horridus read
  • Discus compositum read
  • Gelsemium sempervirens read
  • Hepar sulphuris calcareum read
  • Ignatia amara read
  • Mercurius solubilis read
  • Mucosa compositum read
  • Nux vomica read
  • Plumbum metallicum read
  • Ptelea trifoliata read
  • Rhododendron chrysanthum read
  • Spigelia anthelmia read
  • Zeel t read

Tree of ICD-10 diagnoses

  1. Description
  2. Similar diseases
  3. Related standards of medical care
  4. Basic medical services
  5. Clinics for treatment

Other names and synonyms

T24.7.

Description

There is no detailed description, see related

Similar diseases

Related standards of medical care

42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.